Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.
Pfefferkorn, E R
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. [electronic resource] - Antimicrobial agents and chemotherapy Jan 1994 - 31-7 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
0066-4804
10.1128/AAC.38.1.31 doi
Animals
Azithromycin--pharmacology
Cells, Cultured
Clindamycin--pharmacology
Drug Resistance, Microbial
Fibroblasts--microbiology
Humans
Leucine--metabolism
Mutation
Oxygen Consumption--drug effects
Ribosomes--drug effects
Spiramycin--pharmacology
Toxoplasma--drug effects
Uracil--metabolism
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. [electronic resource] - Antimicrobial agents and chemotherapy Jan 1994 - 31-7 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
0066-4804
10.1128/AAC.38.1.31 doi
Animals
Azithromycin--pharmacology
Cells, Cultured
Clindamycin--pharmacology
Drug Resistance, Microbial
Fibroblasts--microbiology
Humans
Leucine--metabolism
Mutation
Oxygen Consumption--drug effects
Ribosomes--drug effects
Spiramycin--pharmacology
Toxoplasma--drug effects
Uracil--metabolism